• Empowering Community Oncologists in the New Era of Cancer Management: The Immuno-Oncology Regional Meeting Series - Register Now
  • ASCO 2014 Meeting Highlights
  • Earn CME Now
  • Register Now
  • ONS 2014: Highlights in Myltiple Myeloma - View Today!
  • New Options, New Hope: Recent Chemotherapeutic Advances in Metastatic Pancreatic Cancer
  • FAQ's

    FAQ Library

    Respected thought leaders answer frequently asked questions on issues important to your practice – available in video, audio, and transcript formats.

  • FAQ's

    Meeting Highlights

    Video and written highlights from major annual meetings regarding the most current multiple myeloma clinical study findings–one of our most popular features!

  • FAQ's

    CE Activities

    Accredited activities that focus on the assessment, diagnosis and treatment of multiple myeloma. Each activity highlights clinically relevant, timely and accurate scientific information, designed to support you in your search for additional education and improved patient care.

  • Recognizing the Signs and Symptoms of Multiple Myeloma in the Primary Care Setting

What's New

FAQ Library
Dr. Sagar Lonial answers four new FAQs
ASCO Meeting Highlights
ASCO 2014: Highlights in Multiple Myeloma
Noopur Raje, MD – Moderator; P. Leif Bergsagel, MD; A. Keith Stewart, MB ChB; Sagar Lonial, MD; Andrzej Jakubowiak, MD, PhD; Jesus San Miguel, MD, PhD
Journal Club Library
Four new additions focusing on newly diagnosed and relapsed/refractory myeloma studies. Complementary studies on monotherapy and in combination therapies are also explored.
CE Activity
How Should New Agents Be Incorporated Into Treatment?
Kenneth C. Anderson, MD – Moderator, R. Donald Harvey III, PharmD, FCCP, BCOP, and Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
CE Activity
Prognostic Factors in Determining MGUS and Smoldering Multiple Myeloma
Sagar Lonial, MD
CE Activity
New Induction Therapies and Assessing Minimal Residual Disease
Sagar Lonial, MD
CE Activity
How Do I Treat a Non-transplant Patient that Fails to Achieve CR after Primary Therapy?
Shaji Kumar, MD
CE Activity
Is This a High-risk Multiple Myeloma Patient?
Nikhil Munshi, MD